Literature DB >> 8824737

Comparative efficacy of four Ayurvedic formulations in the treatment of acne vulgaris: a double-blind randomised placebo-controlled clinical evaluation.

P Paranjpe1, P H Kulkarni.   

Abstract

Eighty-two patients with acne vulgaris were randomised into five groups. Four different Ayurvedic treatment schedules were given orally for 6 weeks, while one group received a placebo. Physical and clinical investigations were carried out at 2 week intervals. A significant reduction in lesion count was observed in patients receiving Sunder Vati when compared with the placebo and the other Ayurvedic formulations, which failed to produce any significant difference from the pretreatment condition. The drug therapies were well tolerated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8824737     DOI: 10.1016/0378-8741(95)01309-1

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

Review 1.  Plant products as antimicrobial agents.

Authors:  M M Cowan
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  The Role of Herbal Medicine in the Treatment of Acne Vulgaris: A Systematic Review of Clinical Trials.

Authors:  Ana Carolina Proença; Ângelo Luís; Ana Paula Duarte
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-15       Impact factor: 2.650

Review 3.  A review of diagnosis and treatment of acne in adult female patients.

Authors:  A U Tan; B J Schlosser; A S Paller
Journal:  Int J Womens Dermatol       Date:  2017-12-23

4.  Effects and safety of acne vulgaris with external application of herbal medicines: A protocol for systematic review and meta analysis.

Authors:  Jin Zhou; Xiaoxiao Li; Haimin Chen; Zirong Qi; Shujun Shao; Yinshan Tang; Chenglong Jiang
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

Review 5.  Edible Plants and Their Influence on the Gut Microbiome and Acne.

Authors:  Ashley K Clark; Kelly N Haas; Raja K Sivamani
Journal:  Int J Mol Sci       Date:  2017-05-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.